Expansion of Quotient Sciences' UK drug development and manufacturing facilities
Quotient Sciences’ Nottingham and Reading facilities have announced the completion of their facility expansions, providing further capabilities to support their flagship program Translational Pharmaceutics®.
Drug development and manufacturing accelerator Quotient Sciences has completed their expansions and investments in their Nottingham and Reading (both UK) facilities for the delivery and support of fully integrated drug development programs through Translational Pharmaceutics®, Quotient Sciences’ flagship platform.
As a platform, Translational Pharmaceutics integrates programs for drug substance, drug product, and clinical testing activities under a single outsourcing provider, with the goal of accelerating development timelines while reducing costs. The platform, which utilises rapid “make-test” cycles wherein drug products run through the clinical study manufacturing, release, and dosing process in days, was developed with consultation from the MHRA and US FDA. Quotient Sciences’ investments in their expanded laboratory and clinical pharmacology spaces will increase their capacity to conduct programs with Translational Pharmaceutics.
Quotient Sciences Nottingham facility boasts an MHRA-inspected clinical pharmacology facility spanning 17,000 square feet, with processing labs, a dispensary, and controlled storage. The facility sits alongside their existing facilities specialising in formulation development, manufacturing, and clinical operations. Their Reading site has completed a GBP £1.5 million expansion for its early development and manufacturing facility.
Mark Egerton, CEO of Quotient Sciences, commented: “Quotient Science’s mission is to help bring new medicines to patients faster by breaking own traditional industry silos... Our Unique Translational Pharmaceutics platform was launched over 15 years ago and has accelerated the development of close to 1,000 molecules for our customers. These expansions are consistent with our overall growth strategy and in direct response to feedback from our customers and the increasing demand for our services.”
Source: Quotient Sciences Expands UK Facilities to Support the Delivery of Translational Pharmaceutics®
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance